New research at the University of Chicago has found differences in immune pathway activation to influenza infection between individuals of European and African genetic ancestry. Many of the genes that were associated…




New research at the University of Chicago has found differences in immune pathway activation to influenza infection between individuals of European and African genetic ancestry. Many of the genes that were associated…


Professor George Warimwe should be a household name in Kenya. He’s a leading scientist who has created a life-saving vaccine against Rift Valley Fever. He is also leading policy-changing work on Yellow…


A quiet monthslong legal fight between the U.S. National Institutes of Health and drugmaker Moderna over COVID-19 vaccine patents recently burst into public view. The outcome of the battle has important implications,…


It’s no secret that America’s rural critical access hospitals are struggling to keep their doors open and face myriad challenges in providing quality care to their inpatients. But in a new study, University…


As opioid overdose deaths soar during the COVID-19 pandemic, a Michigan Medicine study found that the vast majority of patients treated for opioid overdoses in United States emergency departments don’t receive two potentially…


New research from UC San Francisco that tested possible triggers of a common heart condition, including caffeine, sleep deprivation and sleeping on the left side, found that only alcohol use was consistently…


As the application of facial recognition and DNA technologies increases across industries and domains, questions arise concerning the public’s comfort with biometric modalities, the acceptability of using biometrics in various societal contexts,…
One in five individuals avoided healthcare during lockdown in the COVID-19 pandemic, often for potentially urgent symptoms, according to a new study publishing November 23rd in PLOS Medicine by Silvan Licher of Erasmus University Medical…


Weill Cornell Medicine has received a $1.27 million grant from the United States Department of Defense (DoD) to develop treatment for a rare but devastating eye condition largely affecting military personnel who…